Fiedler Susanne 4
4 · Organon & Co. · Filed Apr 3, 2024
Insider Transaction Report
Form 4
Fiedler Susanne
Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2024-03-31$18.80/sh−1,520$28,576→ 41,953 total - Tax Payment
Common Stock
2024-03-31$18.80/sh−2,483$46,680→ 47,264 total - Exercise/Conversion
Common Stock
2024-03-31+4,771→ 43,473 total - Exercise/Conversion
Common Stock
2024-03-31+7,794→ 49,747 total - Exercise/Conversion
Restricted Stock Units
2024-03-31−4,771→ 4,772 total→ Common Stock (4,771 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-31−7,794→ 15,590 total→ Common Stock (7,794 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock.
- [F2]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025.
- [F3]On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026.